- |||||||||| Enbrel (etanercept) / Pfizer, Amgen
Trial completion: Etanercept for Treatment of Hidradenitis (clinicaltrials.gov) - Feb 27, 2016 P2, N=15, Completed, No longer recruiting --> Completed Recruiting --> Completed
- |||||||||| rifampicin/isoniazid/ethambutol/pyrazinamide / Generic mfg.
Enrollment closed: Essentiality of INH in TB Therapy (clinicaltrials.gov) - Feb 18, 2016 P2, N=69, Active, not recruiting, N=458 --> 310 Recruiting --> Active, not recruiting
- |||||||||| Biomarker, Trial completion, Enrollment change, IO biomarker: BIONEC: Biomarkers in Patients With Flesh-eating Bacterial Infections (clinicaltrials.gov) - Feb 17, 2016
P=N/A, N=169, Completed, Active, not recruiting --> Recruiting | N=12 --> 36 | Trial primary completion date: Mar 2016 --> Nov 2017 Recruiting --> Completed | N=114 --> 169
- |||||||||| ExPEC-4V / J&J, GSK
Trial completion: Vaccine Against Escherichia Coli Infection (clinicaltrials.gov) - Feb 11, 2016 P1, N=194, Completed, Initiation date: Jan 2016 --> May 2016 | Trial primary completion date: Jun 2016 --> Jan 2017 Active, not recruiting --> Completed
- |||||||||| Trial completion, Enrollment change: Detection of Mycoplasma Pneumoniae (clinicaltrials.gov) - Feb 8, 2016
P=N/A, N=471, Completed, Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Feb 2015 Recruiting --> Completed | N=800 --> 471
- |||||||||| sodium phenylbutyrate / Generic mfg.
Trial completion, Trial primary completion date: IRETB: Immune Reconstitution in Tuberculosis Disease (clinicaltrials.gov) - Feb 5, 2016 P2, N=390, Completed, Enrolling by invitation --> Active, not recruiting Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Aug 2015
- |||||||||| Enrollment closed, Enrollment change, Trial primary completion date: Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers (clinicaltrials.gov) - Feb 4, 2016
P=N/A, N=203, Active, not recruiting, Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Aug 2015 Enrolling by invitation --> Active, not recruiting | N=400 --> 203 | Trial primary completion date: Aug 2015 --> Jan 2016
|